ChannelAdvisor IPO ...
Health Care: Health Services
GenMark Diagnostics Inc. (GNMK: NASDAQ)
$14.39 0.39 | 2.79%
05/23/13 - 01:39 PM ET
Company Balance Sheet
| Dec 2012 | Dec 2011 | Dec 2010 | Dec 2009 | |
| Assets | ||||
|---|---|---|---|---|
| Cash and Equivalents | 51.25M | 25.32M | 18.33M | 16.48M |
| Receivables | 3.19M | 1.10M | 677.65K | 169.84K |
| Inventories | 1.99M | 2.17M | 896.81K | 136.97K |
| Other Current Assets | 226.00K | 322.00K | 2.19M | 992.18K |
| Total Current Assets | 58.00M | 33.91M | 22.10M | 17.78M |
| Property, Plant & Equipment, Gross | 12.87M | 7.89M | 7.41M | 5.43M |
| Accumulated Depreciation & Depletion | 5.80M | 5.05M | 4.71M | 4.05M |
| Property, Plant & Equipment, Net | 7.07M | 2.84M | 2.70M | 1.38M |
| Intangibles | 1.83M | 1.36M | 70.98K | 170.05K |
| Other Non-Current Assets | 1.11M | 80.00K | 55.36K | 0.00 |
| Total Non-Current Assets | 10.01M | 4.28M | 2.83M | 1.55M |
| Liabilities & Shareholder Equity | ||||
| Total Assets | 68.02M | 38.19M | 24.93M | 19.33M |
| Accounts Payable | 2.44M | 1.20M | 823.24K | 1.50M |
| Short Term Debt | 638.00K | 1.00M | 0.00 | 0.00 |
| Other Current Liabilities | 185.00K | 2.66M | 1.25M | 886.03K |
| Total Current Liabilities | 9.17M | 6.38M | 3.25M | 3.21M |
| Long Term Debt | 63.00K | 583.00K | 0.00 | 0.00 |
| Deferred Income Taxes | 0.00 | 0.00 | 0.00 | 0.00 |
| Other Non-Current Liabilities | 2.33M | 588.00K | 612.93K | 795.33K |
| Minority Interest | 0.00 | 0.00 | 0.00 | 0.00 |
| Total Non-Current Liabilities | 2.39M | 1.17M | 612.93K | 795.33K |
| Total Liabilities | 11.57M | 7.55M | 3.86M | 4.01M |
| Preferred Stock Equity | 0.00 | 0.00 | 0.00 | 11.78M |
| Common Stock Equity | 56.45M | 30.63M | 21.07M | 3.54M |
| Common Par | 3.00K | 2.00K | 1.17K | 2.57M |
| Additional Paid In Capital | 247.45M | 199.53M | 166.01M | 127.48M |
| Cumulative Translation Adjustment | 0.00 | 0.00 | 0.00 | 0.00 |
| Retained Earnings | -190.57M | -168.46M | -144.49M | -126.09M |
| Treasury Stock | 0.00 | 0.00 | 0.00 | 0.00 |
| Other Equity Adjustments | -436.00K | -436.00K | -449.96K | -415.31K |
| Total Capitalization | 56.51M | 31.22M | 21.07M | 15.32M |
| Total Equity | 56.45M | 30.63M | 21.07M | 15.32M |
| Total Liabilities & Stock Equity | 68.02M | 38.19M | 24.93M | 19.33M |
| Total Common Shares Outstanding | 32.75M | 20.48M | 11.73M | 11.72M |
| Preferred Shares | 0.00 | 0.00 | 0.00 | 0.00 |
| Treasury Shares | 0.00 | 0.00 | 0.00 | 0.00 |
| Basic Weighted Shares Outstanding | 26.22M | 16.57M | 9.80M | 4.53M |
| Diluted Weighted Shares Outstanding | 26.22M | 16.57M | 9.80M | 4.53M |
| Number of Employees | 130 | 82 | 79 | NA |
| Number of Part-Time Employees | 0 | 0 | 0 | NA |
Portfolios with GNMK
- Portfolio NameUser Type
- ContributorStocks Under-$10 Moving Hig...
- ContributorStocks Under-$10 Moving Hig...
- ContributorBarron's Insider Purchases ...
Latest GNMK Headlines from TheStreet
- 4 Stocks Under $5 Making Big Up Moves 07.10.12 | 02:07 pm
- GenMark Diagnostics Inc. Stock Upgraded (GNMK) 06.29.12 | 05:06 am
- GenMark Diagnostics Inc. Stock Downgraded (GNMK) 11.23.11 | 06:11 am
- GenMark Diagnostics Inc. Stock Upgraded (GNMK) 08.26.11 | 07:08 am
- GenMark Diagnostics Inc. Stock Downgraded (GNMK) 08.11.11 | 07:08 am
- GenMark Diagnostics Inc. Stock Upgraded (GNMK) 08.09.11 | 07:08 am
- GenMark Diagnostics To Present At The Piper Jaffray 22nd Annual Health Care Conference 11.24.10 | 09:11 am
- GenMark Diagnostics To Present At William Blair Emerging Growth Stock Conference 10.01.10 | 07:10 am
- GenMark IPO Better than Mirion IPO
05.25.10 | 06:05 am
Press Releases for GNMK
- GenMark Diagnostics Reports Fourth Quarter And Year End 2012 Results - Business Wire 03.12.13 | 04:03 pm
- GenMark Diagnostics Schedules Fourth Quarter And Full Year 2012 Financial Results And Conference Call For March 12, 2013 - Business Wire 02.28.13 | 05:02 pm
- GenMark Diagnostics To Present At The 31st Annual J.P. Morgan Healthcare Conference - Business Wire 01.04.13 | 04:01 pm
- GenMark Diagnostics To Present At The Canaccord Genuity Medical Technology & Diagnostics Forum - Business Wire 11.26.12 | 09:11 am
- GenMark Diagnostics To Present At The Piper Jaffray 24th Annual Healthcare Conference - Business Wire 11.20.12 | 06:11 pm
- GenMark Diagnostics Reports Third Quarter 2012 Results - Business Wire 11.07.12 | 06:11 pm
- GenMark Diagnostics Schedules Third Quarter 2012 Financial Results And Conference Call For November 8, 2012 - Business Wire 10.26.12 | 02:10 pm
- GenMark To Show Its All-Electronic, Sample-to-Answer Molecular Diagnostics Platform At The Association For Molecular Pathology Meeting - Business Wire 10.22.12 | 09:10 am
- GenMark Diagnostics Receives FDA Clearance For RVP Test - Business Wire 09.12.12 | 09:09 am
- GenMark Diagnostics To Present At Canaccord Genuity 32nd Annual Growth Conference - Business Wire 08.15.12 | 09:08 am
Partner Headlines for GNMK
- GenMark Diagnostics Earnings: Everything You Must Know Now - Wall St. Cheat Sheet 05.08.13 | 08:05 am
- FDA Clears GenMark's Newest Test - Analyst Blog - NASDAQ 09.13.12 | 04:09 pm
- Weekly CFO Buys Highlight: XPL, GNMK - GuruFocus 07.02.12 | 12:07 pm
- Weekly CEO Buys Highlight: SXL, JBSS, GNMK, CNDO, DCO - GuruFocus 06.30.12 | 02:06 pm
- GenMark Diagnostics Appoints Richard B. Slansky Chief Financial Officer - Benzinga 04.02.12 | 04:04 pm
- After Shaky August, IPO Market Attempts To Right Itself - Seeking Alpha 09.23.11 | 08:09 am
- 10 Rallying Small-Caps Bought Up By Insiders - Seeking Alpha 09.16.11 | 04:09 pm
- 2010 Year-End U.S. IPO Review and 2011 Outlook - Seeking Alpha 03.04.11 | 02:03 pm
- William Blair & Co. Initiates Outperform Rating on GenMark Diagnostics (GNMK) - Benzinga 07.12.10 | 09:07 am
